This shows you the differences between two versions of the page.
Both sides previous revision Previous revision Next revision | Previous revision Last revision Both sides next revision | ||
documentation:oncology:meeting_notes_2019_mar-12 [2019/03/13 13:19] mgurley |
documentation:oncology:meeting_notes_2019_mar-12 [2019/03/13 13:38] mgurley |
||
---|---|---|---|
Line 12: | Line 12: | ||
* Discussed: How should we handle 'Numeric' NAACCR items that define numeric ranges?:https://github.com/OHDSI/OncologyWG/issues/26 | * Discussed: How should we handle 'Numeric' NAACCR items that define numeric ranges?:https://github.com/OHDSI/OncologyWG/issues/26 | ||
* Resolved "How should we handle NAACCR provenance concepts?": [[https://github.com/OHDSI/OncologyWG/issues/32]] | * Resolved "How should we handle NAACCR provenance concepts?": [[https://github.com/OHDSI/OncologyWG/issues/32]] | ||
- | * Discussed 'How should we handle versions of staging variables? For both TNM and AJCC variables?': [[https://github.com/OHDSI/OncologyWG/issues/31]]: | + | * Discussed 'How should we handle versions of staging variables? For both TNM and AJCC variables?': [[https://github.com/OHDSI/OncologyWG/issues/31]] |
+ | * Resolved "Should we record dates as a separate measurement record.(e.g. Date regional lymph node dissection NAACCR #682)?":https://github.com/OHDSI/OncologyWG/issues/33 | ||
+ | * Resolved "How do we handle different versions of NAACCR?": [[https://github.com/OHDSI/OncologyWG/issues/34]] | ||
| | ||